Table 2 Association between myasthenia gravis and labour market participation during 1- and 2-years follow up
No LMP, n (%) | Unadjusted OR (95% CI) | Adjusted OR (95% CI)a | |
|---|---|---|---|
Comparison groups | No LMP, 1 year after diagnosis/match | ||
MG vs. matched references | 35 (10.6)/309 (4.7) | 2.42 (1.67–3.49) | 2.23 (1.46–3.38) |
MG: age 40+ vs. 18–39 | 22 (11.2)/13 (9.7) | 1.18 (0.57–2.43) | 2.02 (0.84–4.86) |
MG: male vs. female | 10 (7.7)/25 (12.5) | 0.58 (0.27–1.26) | 0.67 (0.28–1.59) |
MG: AChEI+ vs. AChEI | 21 (12.2)/14 (8.9) | 1.43 (0.70–2.92) | 1.26 (0.57–2.78) |
Comparison groups | No LMP, 2 years after diagnosis/match | ||
MG vs. matched references | 75 (22.7)/327 (5.0) | 5.64 (4.26–7.47) | 5.76 (4.13–8.04) |
MG: age 40+ vs. 18–39 | 44 (22.5)/31 (23.1) | 0.96 (0.57–1.62) | 1.21 (0.64–2.27) |
MG: male vs. female | 19 (14.6)/56 (28.0) | 0.44 (0.25–0.78) | 0.39 (0.20–0.74) |
MG: AChEI+ vs. AChEI | 49 (28.5)/26 (16.5) | 2.02 (1.18–3.45) | 1.95 (1.09–3.50) |